8-K
Philip Morris International Inc. (PM)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 22, 2023
Philip Morris International Inc.
(Exact name of registrant as specified in its charter)
| Virginia | 1-33708 | 13-3435103 | |
|---|---|---|---|
| (State or other jurisdiction<br><br>of incorporation) | (Commission File Number) | (I.R.S. Employer<br><br>Identification No.) | |
| 677 Washington Blvd, Ste. 1100 | Stamford | Connecticut | 06901 |
| --- | --- | --- | --- |
| (Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code: (203) 905-2410
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||
|---|---|---|---|---|---|---|
| Common Stock, no par value | PM | New York Stock Exchange | ||||
| 2.625% Notes due 2023 | PM23 | New York Stock Exchange | ||||
| 2.125% Notes due 2023 | PM23B | New York Stock Exchange | ||||
| 3.600% Notes due 2023 | PM23A | New York Stock Exchange | 2.875% Notes due 2024 | PM24 | New York Stock Exchange | |
| --- | --- | --- | ||||
| 2.875% Notes due 2024 | PM24C | New York Stock Exchange | ||||
| 0.625% Notes due 2024 | PM24B | New York Stock Exchange | ||||
| 3.250% Notes due 2024 | PM24A | New York Stock Exchange | ||||
| 2.750% Notes due 2025 | PM25 | New York Stock Exchange | ||||
| 3.375% Notes due 2025 | PM25A | New York Stock Exchange | ||||
| 2.750% Notes due 2026 | PM26A | New York Stock Exchange | ||||
| 2.875% Notes due 2026 | PM26 | New York Stock Exchange | ||||
| 0.125% Notes due 2026 | PM26B | New York Stock Exchange | ||||
| 3.125% Notes due 2027 | PM27 | New York Stock Exchange | ||||
| 3.125% Notes due 2028 | PM28 | New York Stock Exchange | ||||
| 2.875% Notes due 2029 | PM29 | New York Stock Exchange | ||||
| 3.375% Notes due 2029 | PM29A | New York Stock Exchange | ||||
| 0.800% Notes due 2031 | PM31 | New York Stock Exchange | ||||
| 3.125% Notes due 2033 | PM33 | New York Stock Exchange | ||||
| 2.000% Notes due 2036 | PM36 | New York Stock Exchange | ||||
| 1.875% Notes due 2037 | PM37A | New York Stock Exchange | ||||
| 6.375% Notes due 2038 | PM38 | New York Stock Exchange | ||||
| 1.450% Notes due 2039 | PM39 | New York Stock Exchange | ||||
| 4.375% Notes due 2041 | PM41 | New York Stock Exchange | ||||
| 4.500% Notes due 2042 | PM42 | New York Stock Exchange | ||||
| 3.875% Notes due 2042 | PM42A | New York Stock Exchange | ||||
| 4.125% Notes due 2043 | PM43 | New York Stock Exchange | ||||
| 4.875% Notes due 2043 | PM43A | New York Stock Exchange | ||||
| 4.250% Notes due 2044 | PM44 | New York Stock Exchange | ||||
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | ||||||
| --- | ||||||
| Emerging growth company | ☐ | |||||
| --- | --- | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | |||
| --- | --- | |||||
| Item 7.01. | Regulation FD Disclosure. | |||||
| --- | --- |
On February 22, 2023, Philip Morris International Inc. ("PMI") hosted a live audio webcast at the Consumer Analyst Group of New York Conference where PMI’s Chief Financial Officer, Emmanuel Babeau, will address investors. In connection with the presentation, PMI is furnishing to the Securities and Exchange Commission the following documents attached as exhibits to this Current Report on Form 8-K and incorporated by reference to this Item 7.01: (i) the press release, dated February 22, 2023, attached as Exhibit 99.1 hereto; and (ii) the presentation slides, dated February 22, 2023, attached as Exhibit 99.2 hereto.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report on Form 8-K shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as may be expressly set forth by specific reference in such filing or document.
| Item 9.01. | Financial Statements and Exhibits. | | --- | --- || (d) | Exhibits. | | --- | --- | | 99.1 | Philip Morris International Inc. Press Release, dateda20230222cagnypressrelease.htmFebruary22,2023 (furnished pursuant to Item7.01). | | --- | --- | | 99.2 | Presentation Slides, dated February 22, 2023(furnished pursuant to Item7.01). | | --- | --- | | 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document and contained in Exhibit 101) | | --- | --- |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PHILIP MORRIS INTERNATIONAL INC. | |
|---|---|
| By: | /s/ DARLENE QUASHIE HENRY |
| Name: | Darlene Quashie Henry |
| Title: | Vice President, Associate General Counsel & Corporate Secretary |
Date: February 22, 2023
Document
| PRESS RELEASE | Exhibit 99.1<br><br> |
|---|---|
| Investor Relations: | Media: David Fraser |
| Stamford, CT: +1 (203) 904 2410 | Lausanne: +41 (0)58 242 4500 |
| Lausanne: +41 (0)58 242 4666 | Email: David.Fraser@pmi.com |
| Email: InvestorRelations@pmi.com |
PHILIP MORRIS INTERNATIONAL INC. PRESENTS AT
2023 CONSUMER ANALYST GROUP OF NEW YORK (CAGNY) CONFERENCE;
REAFFIRMS 2023 FULL-YEAR FORECAST FOR REPORTED DILUTED EPS
OF $6.09 TO $6.21 AND ADJUSTED DILUTED EPS OF $6.25 TO $6.37,
REPRESENTING CURRENCY-NEUTRAL GROWTH OF 7% TO 9%
STAMFORD, CT, February 22, 2023 – Philip Morris International Inc.’s (PMI) (NYSE: PM) Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2023 Consumer Analyst Group of New York (CAGNY) Conference.
The event will be webcast live in listen-only mode, beginning at approximately 11:00 a.m. ET, at www.pmi.com/2023cagny and on the PMI Investor Relations Mobile Application (accessible on iOS or Android devices). Presentation slides will also be available on the same site and the App. An archived copy of the webcast will be available until 5:00 p.m. ET on Thursday, March 23, 2023, also at www.pmi.com/2023cagny.
The presentation will cover:
•PMI’s progress to date on becoming a predominantly smoke-free business by 2025;
•the powerful financial model underlying the company’s smoke-free transformation;
•the company’s strong multi-category portfolio with leading premium brands in heat-not-burn and oral nicotine;
•PMI’s near-term plans for investing in the commercialization of IQOS in the U.S. and nicotine pouches internationally;
•the role of the company’s combustible tobacco portfolio in its smoke-free transformation;
•PMI’s leadership on sustainability, with a continued focus on the health impact of its products; and
•the company’s capital allocation priorities and unwavering commitment to shareholder returns.
2023 Full-Year Forecast
PMI reaffirms its 2023 full-year reported diluted EPS forecast, announced on February 9th, of $6.09 to $6.21, at then-prevailing exchange rates. Excluding a total 2023 adjustment of $0.16 per share and an unfavorable currency impact, at then-prevailing exchange rates, of $0.15 per share, this forecast represents a projected currency-neutral increase of 7% to 9% versus adjusted diluted EPS of $5.98 in 2022, as outlined in the below table.
| Full-Year | ||||||
|---|---|---|---|---|---|---|
| 2023<br><br>Forecast | 2022 | |||||
| Reported Diluted EPS | $6.09 | - | $6.21 | 5.81 | ||
| Adjustments | ||||||
| Amortization and impairment of intangibles | 0.16 | 0.15 | ||||
| Costs associated with Swedish Match AB offer | ̶ | 0.06 | ||||
| Swedish Match AB acquisition accounting related item | ̶ | 0.06 | ||||
| Tax benefit associated with Swedish Match AB financing | ̶ | (0.13) | ||||
| Charges related to the war in Ukraine | ̶ | 0.08 | ||||
| Fair value adj. for equity security investments | ̶ | (0.02) | ||||
| Tax Items | ̶ | (0.03) | ||||
| Total Adjustments | 0.16 | 0.17 | ||||
| Adjusted Diluted EPS | $6.25 | - | $6.37 | 5.98 | ||
| Less Currency | (0.15) | |||||
| Adjusted Diluted EPS, excluding currency | $6.40 | - | $6.52 | 5.98 | - | 9% |
All values are in US Dollars.
The assumptions underlying this forecast remain unchanged versus those communicated by PMI in its earnings release of February 9, 2023.
Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.
Forward-Looking & Cautionary Statements
The presentation, related discussion and this press release contain projections of future results and goals and other forward-looking statements, including statements regarding business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.
PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of COVID-19 on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency
exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to produce and commercialize reduced-risk products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our reduced-risk product category's performance.
PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2022. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested more than USD 10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration (FDA) has authorized versions of PMI’s IQOS Platform 1 devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products (MRTPs). As of December 31, 2022, PMI's smoke-free products were available for sale in 73 markets, and PMI estimates that approximately 17.8 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 32% of PMI’s total full-year 2022 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma subsidiary, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com.
3
a2-22x2023xcagnyslides
Delivering a Smoke-Free Future CAGNY Conference February 22, 2023 Emmanuel Babeau, Chief Financial Officer Forward-Looking and Cautionary Statements • This presentation contains projections of future results and goals and other forward-looking statements, including statements regarding business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI • PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of COVID-19 on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to produce and commercialize reduced-risk products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our reduced-risk product category's performance • PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2022. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations 2
Global Smoke-Free Champion, Winning Portfolio •Going global with rapid progress on smoke- free transformation:⎼ Excellent IQOS performance supported by ILUMA and 2-tier HTU portfolio⎼ Outstanding ZYN growth⎼ Rich pipeline of smoke-free innovations ⎼ Exciting expansion plans in the U.S. and internationally •On track to be majority smoke-free company •Underlying positive margin dynamic from shift to smoke-free products 3 (a) Unaudited financial information. See Glossary of Key Terms and Definitions, and Reconciliation of Non-GAAP Measures at the end of this presentation for more information Source: PMI Financials or estimates Already Moving Fast in Our Smoke-Free Transformation 4 ~25m IQOS users 2022 Smoke-Free Net Revenues >1/3 PMI & Swedish Match Full Year Combined 3rd Consecutive Year of 3rd Consecutive Year of >7% Organic Net Revenues Growth Targeted in 2023 2022 Smoke-Free Net Revenues ~$12bn PMI & Swedish Match Full Year Combined(a) IQOS #1 ZYN #1 Total Volume Growth Targeted in 2023 Smoke-Free Brand Nicotine Pouch Brand
Swedish Match Accelerates Transformation & Growth 5 Accretive to Growth Note: Total Oral for Swedish Match includes: nicotine pouches, snus and moist snuff Source: PMI Financials or estimates PMI CAGR (2020-22) Volume Growth HTUs 20% Total Volume 1.9% SWMA CAGR (2020-22) Volume Growth Nicotine Pouches 44% Total Oral (in cans) 13% On Track for Predominantly Smoke-Free 2025 Ambition (As a % of PMI Total Adjusted Net Revenues) 6 0.7% 3.3% 13.1% 14.3% 19.2% 24.2% 29.5% 32.1% Approaching 40%(a) >50% 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 Target Ambition (a) 2023 target provided on a constant currency basis Note: Refer to glossary for Smoke-free Products (SFPs) definition. Following the Swedish Match acquisition, PMI reclassified certain of its own products previously reported under its combustible tobacco category to the newly created smoke-free product category to better reflect the characteristics of these products. The impact of the reclassification was immaterial for all periods Source: PMI Financials or estimates Smoke-Free Net Revenues ($ in billion) $0.9 $5.7$4.2$3.8$0.2 $6.9 $9.3 $10.2 >1/3 Incl. Swedish Match
Growing Number of Markets Already >50% Net Revenues 7 2022 Smoke-Free Net Revenues >50% (a) For full year 2022 in markets where IQOS is present at December 31, 2022, as a % of net revenues Source: PMI Financials or estimates 17 Markets +7 vs. PY HungaryCzech Republic Japan Bulgaria Cyprus Lithuania Greece Italy Romania Latvia SloveniaPoland Denmark Slovak Republic ~40% Smoke-Free Net Revenues in markets where IQOS is commercialized(a) 17 Markets Including: Focused on Smoke-Free Categories with Attractive Returns • Significant investment to develop and commercialize smoke-free products • Focus on premium brands in most attractive categories drives profitability •PMI’s smoke-free business has been profitable for several years •Making significant contribution to bottom-line 8 Cigarettes Closed E-Vapor Exclusive Nicotine Pouches Exclusive EU Region Illustrative Category Annual Gross Margin per User (Excluding Devices, Consumables Only, Index = Cigarettes) IQOS HnB Exclusive Note: Reflects indexed dollar gross margin. Cigarettes, closed system e-vapor and IQOS HnB represents average of 5 key markets: France, Italy, Poland, Spain, UK. Nicotine pouches average of Sweden and Denmark where category is more established. Chart not to scale Source: PMI Financials or estimates 8
(a) Chart is not to scale Source: PMI Financials or estimates Rapid Transformation Drives Growth & Profitability 9 Equivalent Cigarette Volumes HnB Consumables Net Revenue Per Unit (Index = Equivalent Cigarette Volumes) % Gross Margin(a) Cigarettes HnB Consumables ~10pp PMI International Share of Segment Cigarettes HnB Consumables ~25% ~75% ~2.5 1 X X Shift to Smoke-Free Products Supports Margin Expansion Over Time • Fundamental positive margin drivers continue:⎼ Higher unit and gross margins on HnB and oral nicotine⎼ Scale benefits, digitization, savings drive operating leverage •Margin headwinds in 2022 and this year:⎼ Higher costs from supply chain disruption, transition to ILUMA, time lag in recovery of inflation through pricing⎼ Progressive improvement through 2023 •Targeting a better 2024 • Investing to drive top and bottom-line growth 10
Strong & Segmented Multi-Category Portfolio With Leading Brands 11 Heat-not-Burn E-VaporOral Nicotine Comprehensive HnB Offer Fulfilling All Consumer Preferences 12Note: Price positions are illustrative only lilILUMA BONDS P re m iu m M ai n st re am Lo w IQOS ORIGINALS (Blade) Multi-tier HTU portfolio driving growth
Successful IQOS ORIGINALS, Next Level Innovation With ILUMA • IQOS ORIGINALS (blade) & HEETS:⎼ Technology that made IQOS successful, #1 smoke-free product in the world⎼ Driving growth worldwide ⎼ Multiple innovative enhancements over the years • IQOS ILUMA & TEREA/SENTIA:⎼ Groundbreaking consumer-centric innovation⎼ Consistently delivering superior experience for higher conversion & retention 13Source: PMI Financials or estimates Further Expansion of Portfolio to Address More Adult Smokers • lil & Fiit – Complementary to IQOS:⎼ Long-term partnership with access to KT&G products and pipeline⎼ Addressing mid- and low-price segment with intuitive innovation⎼ Currently in over 30 markets • BONDS & blends – Latest Heat-not-Burn Innovation:⎼ Simple, convenient & affordable without compromising on reduced risk profile⎼ Especially relevant for Low- and Middle-Income Consumers⎼ Promising initial results in pilot city launches⎼ 2023: Continue learning before deploying on a wider scale 14
(a) Status at December 31, 2022 Note: The number of markets includes International Duty Free Source: PMI Financials or estimates Increasing Roll-out of ILUMA 15 16 Markets Worldwide(a) Markets represent >50% of 2022 HTU Volume 16 Markets Including: Japan SwitzerlandSpain GreeceCyprus Portugal South Korea Czech Republic Slovak Republic UAE LithuaniaItaly ILUMA’s 2-Tier HTU Portfolio Driving Growth in Japan 16 (a) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and HTUs Note: New users are former Legal Age Smokers or Legal Age Nicotine Users Source: PMI Financials or estimates. Data until February 5, 2023 Japan HTU Offtake Share(a) 0% 5% 10% 15% 20% 25% July Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun July Aug Sep Oct Nov Dec Jan Marlboro Heatsticks (2.0%) TEREA (17.5%) HEETS (0.8%) Total PMI HTU (27.6%) SENTIA (6.8%) TEREA + SENTIA (24.3%) 2021 2022 TEREA #1 Smoke-Free Brand SENTIA #2 Smoke-Free Brand 2023
ILUMA Accelerating Growth in Italy 17 Italy HTU Offtake Volumes(a) (Index = Jan 2022) 100.0 97.7 104.5 112.1 114.3 116.0 116.8 117.7 116.0 116.4 113.8 117.2 123.6 Jan Feb March Apr May June July Aug Sept Oct Nov Dec Jan 2022 2023 Launch Date December 2022 Rome +3.6pp 25.2% 21.6% Q4’21 Q4’22 Milan 20.1% 16.5% +3.6pp Torino 13.1% 11.1% +2.0pp PMI HTU Offtake Shares (a) 2 month moving average Source: PMI Financials or estimates PMI HTU Market Share Exceeds 15% in 10 Markets 18 22 Key Cities Where PMI HTUs SoM > 15% Q4’22 PMI HTUs SoM (a) Including cigarillos industry Note: Market share for HTUs is defined as the total sales volume for PMI HTUs as a percentage of the total estimated sales volume for cigarettes and HTUs Source: PMI Financials or estimates Czech Republic 16% Greece 18% Italy 15% Portugal 19% Japan(a) 24% Lithuania 31% Cyprus 26% Hungary 28% 10 Markets Including:
(a) Including cigarillos industry Note: Key Cities selected are respectively: Prague, Athens, Budapest, Rome, Tokyo and London Source: PMI Financials or estimates National Shares Follow Key City Shares Over Time National Shares in Q4’22 vs. Key City Shares in Q4’20 19 PMI HTU Key City Offtake SharePMI HTU National IMS Share Czech Republic 10.2% 15.9%16.5% 18.9% Q4 2020 Q4 2022 Japan(a) 20.1% 24.3%24.9% 30.4% Q4 2020 Q4 2022 Italy 9.6% 15.4%16.4% 25.2% Q4 2020 Q4 2022 Greece 13.1% 18.1%19.8% 26.6% Q4 2020 Q4 2022 U.K. 1.8% 3.3%3.8% 7.2% Q4 2020 Q4 2022 Hungary 13.3% 27.5% 17.7% 32.7% Q4 2020 Q4 2022 1 2 3 4 6 8 10 13 17 25 35 50 69 84 103 114 126 143 157 174 187 203 220 238 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2017 2018 2019 2020 2021 2022 Stellar U.S. ZYN Growth Continues 20 ZYN U.S. Shipment Volumes (12 months rolling, million cans) Source: Swedish Match reported shipments and estimates based on MSA weekly data and IRi Unify 75.7% Q4’22 ZYN Category Retail Share (13-week period) 66.6 64.1 64.3 65.3 66.0 64.9 66.5 67.5 ZYN Category Share (in %, 13-week period)
Growth Driven by Increasing Distribution & Velocities 21 Note: MSA data does not cover 100% of U.S. market Source: Swedish Match estimates of distributor shipments to retail using MSA weekly data. Distribution based on stores ordering ZYN over the past 13 weeks period. Velocity measured in periods of 13 weeks IMS Velocities in the U.S. (Cans per Store per Week) 27.9 28.4 29.8 31.5 33.5 34.3 Q3 Q4 Q1 Q2 Q3 Q4 2021 2022 +21% Vs. Q4’21 116 120 124 130 133 138 Q3 Q4 Q1 Q2 Q3 Q4 2021 2022 +19% Vs. Q4’21 Store Count in the U.S. (in Thousands) Strong Progress in the West, Indicator of National Potential Nicotine Pouch Category vs. Cigarette Category 22Note: Western region excludes the following states: Alaska, Hawaii, Idaho and Montana, due to differences in geographic definitions between IRi data and Swedish Match’s regional sales structure Source: IRi Unify Volume (Cans / Packs) Western Region Total U.S. Retail Value Volume (Cans / Packs) Retail Value 0.2% 0.8% 2.5% 5.3% 9.1% 13.1% 2017 2018 2019 2020 2021 2022 0.2% 0.6% 1.6% 3.3% 4.8% 6.7% 2017 2018 2019 2020 2021 2022 0.0% 0.1% 0.5% 1.5% 2.8% 4.5% 2017 2018 2019 2020 2021 2022 0.0% 0.1% 0.4% 1.0% 1.7% 2.5% 2017 2018 2019 2020 2021 2022
Large U.S. Opportunity for IQOS and ZYN • Estimated $20 billion nicotine profit pool • Significantly higher average unit margins vs. international average •No cannibalization from cigarette business • Leading the industry with substantiated reduced risk products:⎼General snus and IQOS the only MRTP authorized smoke-free products •Clear regulatory framework, ability to communicate with adult smokers 23Source: PMI Financials or estimates IQOS in the U.S.: Investing for Success with Benefit to ZYN 24 Operational Model Sales & Distribution Digital Commercial Tools Customer Care / Reverse Logistics Brand RetailManufacturing Regulatory Engagement
IQOS U.S. Commercial Approach • Initial launch in focused geographies:⎼ Openness to innovation and adult smoker population factors in market selection⎼ IQOS 3 with 5 FDA-authorized Tobacco & Menthol HTU variants • Infrastructure investments are up-front •Majority of commercial investment proportionate to volume and states launched •Benefit of knowhow and commercial tools already available in other markets 25 International Opportunity for Nicotine Pouches • Strong progress on Swedish Match integration • Dedicated PMI and Swedish Match team focused on global deployment:⎼ White space markets ⎼ Markets where category is already present⎼ Target up to 10 launches / relaunches in 2023 • Working on developing the category, portfolio of offerings • Committed to responsible commercialization • Other innovative forms of oral nicotine being explored 26
Continuing to Develop E-Vapor Portfolio •Committed to responsible and profitable development • Landscape and user preferences continue to evolve •Building a portfolio addressing category dynamics • Further roll-out of VEEV and VEEBA •Category economics still inferior to HnB and oral smokeless due to product proliferation, lower consumer brand loyalty and conversion rates 27 Shaping Tobacco Harm Reduction •Transformation of our industry and achieve positive differentiation for smoke-free products, accelerating the switching of smokers(a) to better alternatives • Scientifically-substantiated products can switch consumers out of cigarettes much faster than restrictive measures only •Differentiated fiscal and regulatory frameworks are warranted for smoke-free products •Positive public health outcomes can be significantly accelerated with the joint efforts of industry, policy makers and society Over 1 billion Smokers Worldwide We continue to support regulatory and fiscal frameworks which recognize the substantial risk reduction potential of smoke-free products compared with combusted tobacco (a) Adult smokers who would otherwise continue smoking 28
Encouraging Fiscal & Regulatory Developments •More markets providing visibility on excise tax duties with differentials:⎼ 20+ markets have multi-year tax calendars for HTPs, incl. growing number in EU •Additional markets implemented regulatory frameworks for nicotine pouches •Opening new markets:⎼ Taiwan introducing legislation regulating HTPs • Securing better regulation for harm reduction:⎼ Philippines dedicated regulatory framework for smoke-free products •Positive momentum, with more potential opportunities 29 Remaining Competitive and Maintaining Leadership in Combustibles: Key Pillar of Smoke-Free Strategy • Leading combustible portfolio • Infrastructure and expertise (manufacturing, regulatory, commercial) •Maintaining connection with adult smokers and the retail trade •Responsible stewardship: market leader driving the obsolescence of the category •Target at least stable combustible share net of cannibalization • Selectively investing to continue leadership •Driving returns from pricing, digital efficiency and productivity 30
Delivering on Strategy With Robust Combustible Performance • Sharper focus with category management structure • Strong pricing supporting robust net revenue growth in 2022 •Positive category share despite impact of IQOS cannibalization 31 Note: Excludes China and the U.S and includes cigarillos in Japan. Reflects sales volume of PMI cigarettes as a percentage of cigarette industry sales volume Source: PMI Financials or estimates Share of Cigarette Category 24.8% 24.6% 24.7% 25.2% 25.1% 2021 Q1 Q2 Q3 Q4 2022 9.5% 9.6% 9.6% 9.9% 9.9% 2021 Q1 Q2 Q3 Q4 Marlboro: Growing Share & Volumes, 50 Years at Number One 32 Note: Excluding China and the U.S. and includes cigarillos in Japan. Reflects sales volume of Marlboro cigarettes as a percentage of cigarette industry sales volume Source: PMI Financials or estimates 2022 Marlboro Share of Category
Sustainability at the Core of Our Strategy • Enhancing approach to sustainability in 2022:⎼ Updated statement of purpose ⎼ Reassessed ESG priorities⎼ Published dedicated Sustainability Materiality report⎼ Introduced Sustainability Index • Product health impact:⎼ Growing penetration of smoke-free products to accelerate the end of smoking 33 Addressing Our Environmental Footprint 34
Growing, Investing, Deleveraging & Rewarding Shareholders • Highly cash generative business, enhanced by Swedish Match:⎼ Reinvesting in innovation and growth⎼ Focus on deleveraging⎼ Swedish Match $11bn bridge facility fully repaid⎼ Improving currency profile • Target robust EBITDA growth • Unwavering commitment to shareholder returns:⎼ Fifteen consecutive years of dividend growth⎼ Total increase of ~176% since 2008 35 Note: Dividends for 2008 and 2022 are annualized rates. The 2008 annualized rate is based on a quarterly dividend of $0.46 per common share, declared June 18, 2008. The 2022 annualized rate is based on a quarterly dividend of $1.27 per common share, declared September 14, 2022 Source: PMI Financials or estimates $1.84 $5.08 2008 2022 PMI Dividend CAGR: 7.5% Accelerating Our Transformation for Sustainable Returns •Global smoke-free champion with winning portfolio • Fundamentals of IQOS remain very strong • Swedish Match & ZYN accretive to smoke-free growth •The U.S. and international pouches provide major untapped upside •Delivering sustainable growth while investing and rewarding shareholders 36Source: PMI Financials or estimates
Delivering a Smoke-Free Future CAGNY Conference February 22, 2023 iOS Download Android DownloadHave you downloaded the PMI Investor Relations App? The free IR App is available to download at the Apple App Store for iOS devices and at Google Play for Android mobile devices Or go to: www.pmi.com/irapp 38 Glossary of Key Terms and Definitions, and Reconciliation of Non-GAAP Measures
Glossary: General Terms • "PMI" refers to Philip Morris International Inc. and its subsidiaries. Trademarks and service marks that are the registered property of, or licensed by, the subsidiaries of PMI, are italicized • Until March 28, 2008, PMI was a wholly owned subsidiary of Altria Group, Inc. ("Altria"). Since that time the company has been independent and is listed on the New York Stock Exchange (ticker symbol "PM") • Comparisons are made to the same prior-year period unless otherwise stated • References to total industry, total market, PMI shipment volume and PMI market share performance reflect cigarettes and heated tobacco units, unless otherwise stated • As of the first quarter of 2022, total industry volume, PMI in-market sales volume and PMI market share for the following geographies include the cigarillo category in Japan: the total international market, East Asia & Australia Region, and Japanese domestic market • References to total international market, defined as worldwide cigarette and heated tobacco unit volume excluding the U.S., total industry, total market and market shares are PMI estimates for tax-paid products based on the latest available data from a number of internal and external sources and may, in defined instances, exclude the People's Republic of China and/or PMI's duty free business • 2021 and 2022 estimates for total industry volume and market share in certain geographies reflect limitations on the availability and accuracy of industry data during pandemic-related restrictions • "OTP" is defined as "other tobacco products," primarily roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos, and does not include reduced-risk products • "Combustible tobacco products" is the term PMI uses to refer to cigarettes and other tobacco products that are combusted • In-market sales, or "IMS," is defined as sales to the retail channel, depending on the market and distribution model • "Total shipment volume" is defined as the combined total of cigarette shipment volume and heated tobacco unit shipment volume • In the third quarter of 2021, PMI acquired Fertin Pharma A/S, Vectura Group plc. and OtiTopic, Inc. On March 31, 2022, PMI launched a new Wellness and Healthcare business consolidating these entities, Vectura Fertin Pharma. The operating results of this new business are reported in the Wellness and Healthcare segment. The business operations of PMI's Wellness and Healthcare segment are managed and evaluated separately from the geographical segments • "RBH" refers to PMI’s Canadian subsidiary, Rothmans, Benson & Hedges Inc. 39 Glossary: General Terms (cont.) • The Companies’ Creditors Arrangement Act (CCAA) is a Canadian federal law that permits a Canadian business to restructure its affairs while carrying on its business in the ordinary course • "EU" is defined as the European Union Region • "EE" is defined as the Eastern Europe Region • "ME&A" is defined as the Middle East & Africa Region and includes PMI's duty free business • "S&SA" is defined as the South & Southeast Asia Region • "EA&A" is defined as the East Asia & Australia Region • “AMCS” is defined as the Americas Region. It refers to the former Latin America & Canada segment, which was renamed as the Americas segment as of the third quarter of 2021. References to "Americas" may, in defined instances, exclude the U.S. • Following the deconsolidation of PMI's Canadian subsidiary, Rothmans, Benson & Hedges, Inc. (RBH), PMI will continue to report the volume of brands sold by RBH for which other PMI subsidiaries are the trademark owner. These include HEETS, Next, Philip Morris and Rooftop • From time to time, PMI’s shipment volumes are subject to the impact of distributor inventory movements, and estimated total industry/market volumes are subject to the impact of inventory movements in various trade channels that include estimated trade inventory movements of PMI’s competitors arising from markets specific factors that significantly distort reported volume disclosures. Such factors may include changes to the manufacturing supply chain, shipment methods, consumer demand, timing of excise tax increases or other influences that may affect the timing of sales to customers. In such instances, in addition to reviewing PMI shipment volumes and certain estimated total industry/market volumes on a reported basis, management reviews these measures on an adjusted basis that excludes the impact of distributor and/or estimated trade inventory movements. Management also believes that disclosing PMI shipment volumes and estimated total industry/market volumes in such circumstances on a basis that excludes the impact of distributor and/or estimated trade inventory movements, such as on an IMS basis, improves the comparability of performance and trends for these measures over different reporting periods • "ESG" stands for environmental, social, and governance • "Illicit trade" refers to domestic non-tax paid products • "SoM" stands for share of market 40
Glossary: Financial Terms • Adjusted net revenues exclude the impact related to the Saudi Arabia customs assessments • “COGS“ stands for Cost Of Goods Sold • "SG&A" stands for selling, general & administrative • "Adjusted Operating Income Margin" is calculated as adjusted operating income, divided by adjusted net revenues • "Net debt" is defined as total debt, less cash and cash equivalents • Growth rates presented on an organic basis reflect adjusted results, excluding currency, acquisitions and disposals • Management reviews net revenues, operating income, operating income margin, operating cash flow and earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and other items such as acquisitions, asset impairment and exit costs, tax items and other special items. Additionally, starting in 2022 and on a comparative basis, for these measures other than net revenues and operating cash flow, PMI will include adjustments to add back amortization expense on, and impairment of, acquisition related intangible assets that are recorded as part of purchase accounting and contribute to PMI’s revenue generation, as well as impairment of intangible assets, if any. Currency-neutral and organic growth rates reflect the way management views underlying performance for these measures. PMI believes that such measures provide useful insight into underlying business trends and results. Management reviews these measures because they exclude changes in currency exchange rates and other factors that may distort underlying business trends, thereby improving the comparability of PMI’s business performance between reporting periods. Furthermore, PMI uses several of these measures in its management compensation program to promote internal fairness and a disciplined assessment of performance against company targets. PMI discloses these measures to enable investors to view the business through the eyes of management • The company believes that operating income / EPS adjusted for the amortization and impairment of acquired intangibles better reflects the underlying performance of the business and provides a better comparison to past operating performance. This partly reflects the non-cash nature of amortization expense. In addition, amortization of intangibles is driven by the purchase price allocated to a specific asset and is varied across acquisitions because of unique facts and circumstances, timing and terms of acquisition which result in amortization charges that could be inconsistent in size as compared to the revenues generated by those assets • "Fair value adjustment for equity security investments" reflects the adjustment resulting from share price movements in passive investments for publicly traded entities that are not controlled or influenced by PMI. Under U.S. GAAP, such adjustments are required, since January 1, 2018, to be reflected directly in the income statement 41 Glossary: Smoke-Free Products • Smoke-Free Products ("SFPs”) is the term PMI primarily uses to refer to all of its products that are not combustible tobacco products, such as heat-not- burn, e-vapor, and oral nicotine. In addition, SFPs include wellness and healthcare products as well as consumer accessories such as lighters and matches • Reduced-risk products (“RRPs”) is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. PMI's RRPs are smoke-free products that contain and/or generate far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke • Wellness and Healthcare products primarily consist of products related to inhaled therapeutics and oral and intra-oral delivery systems that are included in the operating results of PMI's new Wellness and Healthcare business, Vectura Fertin Pharma • "Aerosol" refers to a gaseous suspension of fine solid particles and/or liquid droplets • "Combustion" is the process of burning a substance in oxygen, producing heat and often light • "Smoke" is a visible suspension of solid particles, liquid droplets and gases in air, emitted when a material burns • "Heated tobacco units," or "HTUs," is the term PMI uses to refer to heated tobacco consumables, which include the company’s BLENDS, HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro and HEETS FROM MARLBORO (defined collectively as HEETS), Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, SENTIA and TEREA, as well as the KT&G-licensed brands, Fiit and Miix (outside of South Korea) • Unless otherwise stated, all references to IQOS are to PMI's Platform 1 IQOS devices and heated tobacco consumables • IQOS heat-not-burn devices are precisely controlled heating devices into which a specially designed and proprietary tobacco units are inserted and heated to generate an aerosol • "PMI heat-not-burn products" include licensed KT&G heat-not-burn products • "PMI HTUs" include licensed KT&G HTUs • HTU "offtake volume" represents the estimated retail offtake of HTUs based on a selection of sales channels that vary by market, but notably include retail points of sale and e-commerce platforms • HTU "offtake share" represents the estimated retail offtake volume of HTUs divided by the sum of estimated total offtake volume for cigarettes and HTUs • Market share for HTUs is defined as the in-market sales volume for HTUs as a percentage of the total estimated industry sales volume for cigarettes and HTUs. For Japan, total estimated industry sales volume also includes cigarillos 42
Glossary: Smoke-Free Products (cont.) • "Total IQOS users" is defined as the estimated number of Legal Age (minimum 18 years) users of PMI heat-not-burn products, for which PMI HTUs represented at least a portion of their daily tobacco consumption over the past seven days The estimated number of adults who have "switched to IQOS and stopped smoking" reflects:⎼ for markets where there are no heat-not-burn products other than PMI heat-not-burn products: daily individual consumption of PMI HTUs represents the totality of their daily tobacco consumption in the past seven days⎼ for markets where PMI heat-not-burn products are among other heat-not-burn products: daily individual consumption of HTUs represents the totality of their daily tobacco consumption in the past seven days, of which at least 70% is PMI HTUs. Note: The above IQOS user metrics reflect PMI estimates, which are based on consumer claims and sample-based statistical assessments with an average margin of error of +/-5% at a 95% Confidence Interval in key volume markets. The accuracy and reliability of IQOS user metrics may vary based on individual market maturity and availability of information As of December 2020, PMI heat-not-burn products and HTUs include licensed KT&G heat-not-burn products and HTUs, respectively • "FDA" stands for the U.S. Food & Drug Administration • "MRTP" stands for Modified Risk Tobacco Product, the term used by the U.S. FDA to refer to RRPs • "MRTP application" stands for Modified Risk Tobacco Product application under section 911 of the FD&C Act • "PMTA" stands for Premarket Tobacco Application under section 910 of the FD&C Act • "Acquisition" refers to our efforts to switch LAS from smoking cigarettes to RRPs or to switch LAU from competing smoke-free products to PMI’s RRPs • "Retention" refers to our efforts to deter LAU from going back to smoking cigarettes or from choosing a competing smoke-free product instead of a PMI RRP 43 PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries Pro Forma Financial Information – PMI and Swedish Match Full Year Combined 44 ($ in millions) / (Unaudited) Note: Sum of product categories or Regions might not foot to total due to roundings The unaudited pro forma combined financial information was prepared using the acquisition method of accounting and was based on the historical financial information of PMI and Swedish Match as disclosed in Form 10-K for the year ended December 31, 2022, Item 8, Note 3. Acquisitions The unaudited pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January 1, 2022. In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company, nor does it reflect the expected realization of any synergies or cost savings associated with the acquisition Year Ended December 31, 2022 Combustible Tobacco Smoke-free Total Net Revenues Total PMI $ 21,572 $ 10,190 $ 31,762 Swedish Match 70 246 316 Net Revenues Total PMI (excl. Swedish Match) $ 21,502 $ 9,944 $ 31,446 Swedish Match Pro Forma Financial Information 514 1,730 2,244 Net Revenues (Pro Forma Combined Financial Information) $ 22,016 $ 11,674 $ 33,690
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries Reconciliation of Non-GAAP Measures 45 Net Revenues by Product Category ($ in millions) / (Unaudited) (a) Includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessment. Excluding this impact total PMI adjusted net revenues are $31,651 million and for combustible tobacco $22,313 million Note: Sum of product categories or Regions might not foot to Total PMI due to roundings. "-" indicates amounts between -$0.5 million and +$0.5 million Years Ended December 31, Net Revenues Combustible Tobacco 2015 2016 2017 2018 2019 2020 2021 2022 European Union $ 8,038 $ 8,104 $ 8,048 $ 8,432 $ 8,093 $ 8,052 $ 8,211 $ 7,212 Eastern Europe 2,735 2,478 2,656 2,597 2,438 2,250 2,240 2,410 Middle East & Africa 4,605 4,489 3,865 3,701 3,691 3,005 3,110 (a) 3,567 South & Southeast Asia 4,288 4,396 4,417 4,656 5,094 4,395 4,385 4,372 East Asia & Australia 3,880 3,619 3,155 3,074 2,693 2,468 2,414 2,138 Americas 3,050 2,731 2,828 2,917 2,074 1,577 1,706 1,804 Swedish Match - - - - - - - 70 Total Combustible Tobacco $ 26,595 $ 25,818 $ 24,970 $ 25,378 $ 24,083 $ 21,747 $ 22,067 $ 21,572 Smoke-free excl. W&H 2015 2016 2017 2018 2019 2020 2021 2022 European Union $ 30 $ 58 $ 270 $ 866 $ 1,724 $ 2,650 $ 4,064 $ 4,907 Eastern Europe - 6 55 324 844 1,128 1,304 1,315 Middle East & Africa 24 27 123 413 351 83 183 334 South & Southeast Asia - - - - - 1 11 23 East Asia & Australia 35 666 3,218 2,506 2,671 2,961 3,539 2,994 Americas 109 111 113 139 132 124 137 99 Swedish Match - - - - - - - 246 Total Smoke-free excl. W&H $ 199 $ 867 $ 3,778 $ 4,247 $ 5,722 $ 6,947 $ 9,237 $ 9,919 Wellness and Healthcare 2015 2016 2017 2018 2019 2020 2021 2022 Wellness and Healthcare $ - $ - $ - $ - $ - $ - $ 101 $ 271 Smoke-free incl. W&H 2015 2016 2017 2018 2019 2020 2021 2022 Smoke-free incl. W&H $ 199 $ 867 $ 3,778 $ 4,247 $ 5,722 $ 6,947 $ 9,338 $ 10,190 PMI 2015 2016 2017 2018 2019 2020 2021 2022 European Union $ 8,068 $ 8,162 $ 8,318 $ 9,298 $ 9,817 $ 10,702 $ 12,275 $ 12,119 Eastern Europe 2,735 2,484 2,711 2,921 3,282 3,378 3,544 3,725 Middle East & Africa 4,629 4,516 3,988 4,114 4,042 3,088 3,293 (a) 3,901 South & Southeast Asia 4,288 4,396 4,417 4,656 5,094 4,396 4,396 4,395 East Asia & Australia 3,915 4,285 6,373 5,580 5,364 5,429 5,953 5,132 Americas 3,159 2,842 2,941 3,056 2,206 1,701 1,843 1,903 Swedish Match - - - - - - - 316 Wellness and Healthcare - - - - - - 101 271 Total PMI $ 26,794 $ 26,685 $ 28,748 $ 29,625 $ 29,805 $ 28,694 $ 31,405 $ 31,762 Delivering a Smoke-Free Future CAGNY Conference February 22, 2023